# Cyanotech Corp.; Filing of Food Additive Petition
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice.
**SUMMARY:**
The Food and Drug Administration (FDA) is announcing that Cyanotech Corp. has filed a petition proposing that the food additive regulations be amended to provide for the safe use of *Haematococcus* algae astaxanthin as a nutrient supplement.
**FOR FURTHER INFORMATION CONTACT:**
James C. Wallwork, Center for Food Safety and Applied Nutrition (HFS-215), Food and Drug Administration, 5100 Paint Branch Pkwy, College Park, MD 20740, 202-418-3078.
**SUPPLEMENTARY INFORMATION:**
Under the Federal Food, Drug, and Cosmetic Act (sec. 409(b)(5) (21 U.S.C. 348(b)(5))), notice is given that a food additive petition (FAP 2A4732) has been filed by Cyanotech Corp., c/o T. Todd Lorenz, 11034 West Ocean Air Dr., # 252, San Diego, CA 92130. The petition proposes to amend the food additive regulations in part 172 * Food Additives Permitted for Direct Addition to Food for Human Consumption * (21 CFR part 172) to provide for the safe use of *Haematococcus* algae astaxanthin as a nutrient supplement.
The agency has determined under 21 CFR 25.32(r) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.
Dated: March 29, 2002.
Leslye M. Fraser,
Acting Director of Regulations and Policy, Center for Food Safety and Applied Nutrition.